I've got at least one more post in this series directly relating to the neuropathy study to which concerns over BG levels over 140 mg/dL and nerve damage can be traced.
This post is actually going to be rather short. In the study, they found that half of those with neuropathy were diagnosed with IGT having a BG level over 140 mg/dL at the 2 hr mark on an OGTT. An additional 18% were diabetic and 32% normoglycemic. So the incidence of IGT was roughly three times as prevalent in this neuropathic population as in the general population. Further, the IGT group had more painful sensory symptoms than the normoglycemic group. But here's the thing:
